DrugCite
Search

CHONDROSULF

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Chondrosulf Adverse Events Reported to the FDA Over Time

How are Chondrosulf adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Chondrosulf, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Chondrosulf is flagged as the suspect drug causing the adverse event.

Most Common Chondrosulf Adverse Events Reported to the FDA

What are the most common Chondrosulf adverse events reported to the FDA?

Agranulocytosis
9 (4.43%)
Drug Rash With Eosinophilia And Sys...
5 (2.46%)
Pyrexia
5 (2.46%)
Renal Failure
5 (2.46%)
Cheilitis
4 (1.97%)
Dermatitis Exfoliative
4 (1.97%)
Eosinophilia
4 (1.97%)
Inflammation
4 (1.97%)
Transaminases Increased
4 (1.97%)
Anaemia
3 (1.48%)
Angioimmunoblastic T-cell Lymphoma
3 (1.48%)
Show More Show More
C-reactive Protein Increased
3 (1.48%)
Constipation
3 (1.48%)
Coordination Abnormal
3 (1.48%)
Cytolytic Hepatitis
3 (1.48%)
Depressed Level Of Consciousness
3 (1.48%)
Dermatitis
3 (1.48%)
Hyperhidrosis
3 (1.48%)
Memory Impairment
3 (1.48%)
Nausea
3 (1.48%)
Pruritus
3 (1.48%)
Purpura
3 (1.48%)
Rash
3 (1.48%)
Skin Erosion
3 (1.48%)
Thrombocytopenia
3 (1.48%)
Vomiting
3 (1.48%)
Acute Coronary Syndrome
2 (.99%)
Acute Generalised Exanthematous Pus...
2 (.99%)
Acute Respiratory Failure
2 (.99%)
Arthritis
2 (.99%)
Bronchopneumopathy
2 (.99%)
Dermatitis Bullous
2 (.99%)
Diarrhoea
2 (.99%)
Erythema Multiforme
2 (.99%)
Eyelid Oedema
2 (.99%)
Fall
2 (.99%)
Hyponatraemia
2 (.99%)
Myocardial Infarction
2 (.99%)
Rash Macular
2 (.99%)
Rash Pustular
2 (.99%)
Respiratory Disorder
2 (.99%)
Skin Exfoliation
2 (.99%)
Troponin Increased
2 (.99%)
Acidosis
1 (.49%)
Acute Febrile Neutrophilic Dermatos...
1 (.49%)
Amnesia
1 (.49%)
Amyotrophic Lateral Sclerosis
1 (.49%)
Angiolipoma
1 (.49%)
Antinuclear Antibody Positive
1 (.49%)
Arrhythmia
1 (.49%)
Asthenia
1 (.49%)
Asthma
1 (.49%)
Biliary Cyst
1 (.49%)
Blood Glucose Increased
1 (.49%)
Bone Marrow Failure
1 (.49%)
Bundle Branch Block Right
1 (.49%)
Chest Pain
1 (.49%)
Choking
1 (.49%)
Confusional State
1 (.49%)
Coronary Artery Disease
1 (.49%)
Cough
1 (.49%)
Culture Urine Positive
1 (.49%)
Cyanosis
1 (.49%)
Cyst
1 (.49%)
Drug Hypersensitivity
1 (.49%)
Dysphagia
1 (.49%)
Dysphonia
1 (.49%)
Dyspnoea
1 (.49%)
Ear Pain
1 (.49%)
Face Oedema
1 (.49%)
Gastrooesophageal Reflux Disease
1 (.49%)
Gingival Bleeding
1 (.49%)
Grand Mal Convulsion
1 (.49%)
Grunting
1 (.49%)
Haematoma
1 (.49%)
Heart Rate Decreased
1 (.49%)
Hepatic Neoplasm
1 (.49%)
Hepatic Steatosis
1 (.49%)
Herpes Zoster
1 (.49%)
Hip Arthroplasty
1 (.49%)
Hyperlactacidaemia
1 (.49%)
Infection
1 (.49%)
Laryngeal Oedema
1 (.49%)
Leukocytosis
1 (.49%)
Lip Pain
1 (.49%)
Livedo Reticularis
1 (.49%)
Liver Injury
1 (.49%)
Loss Of Consciousness
1 (.49%)
Lymphadenopathy
1 (.49%)
Malaise
1 (.49%)
Metabolic Acidosis
1 (.49%)
Mouth Ulceration
1 (.49%)
Mucosal Erosion
1 (.49%)
Multi-organ Failure
1 (.49%)
Neutropenia
1 (.49%)
Odynophagia
1 (.49%)
Oedema
1 (.49%)
Oedema Peripheral
1 (.49%)
Oesophagitis Ulcerative
1 (.49%)
Photophobia
1 (.49%)
Pleural Effusion
1 (.49%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Chondrosulf, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Chondrosulf is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Chondrosulf

What are the most common Chondrosulf adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Chondrosulf, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Chondrosulf is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Chondrosulf According to Those Reporting Adverse Events

Why are people taking Chondrosulf, according to those reporting adverse events to the FDA?

Osteoarthritis
40
Drug Use For Unknown Indication
10
Polyarthritis
7
Product Used For Unknown Indication
6
Arthropathy
4
Musculoskeletal Pain
4
Show More Show More
Fibromyalgia
3
Hernia
3
Osteoporosis
2
Intervertebral Disc Protrusion
2
Ill-defined Disorder
1

Chondrosulf Case Reports

What Chondrosulf safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Chondrosulf. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Chondrosulf.